Synapse - Marjorie Zauderer

Search Within

Marjorie G Zauderer

Results (189)

Improved survival among patients with malignant pleural mesotheliomas who develop immune-related adverse events on immunotherapy

Meeting Abstract

Offin, M.; Egger, J. V.; McCarthy, C. G.; Rudneva, V.; Beattie, J.; Ginsberg, M. S.; Sauter, J. L.; Rimner, A.; Rusch, V. W.; Adusumilli, P. S.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Provision of subspecialized expert oncology (SEO) opinions using Navya Cancer Data Model (NCDM), a technology-based platform: Prospective study to facilitate access to care

Meeting Abstract

Traina, T. A.; Kantoff, P. W.; Matasar, M. J.; Dunn, L.; Friedman, C. F.; Voss, M. H.; Seidman, A. D.; Cahlon, O.; Zauderer, M. G.; Manship, C.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

A Phase III randomized trial of pleurectomy/decortication plus chemotherapy with or without adjuvant hemithoracic intensity-modulated pleural radiation therapy (IMPRINT) for malignant pleural mesothelioma (MPM) (NRG LU-006)

Meeting Abstract

Rimner, A.; Hu, C.; Rusch, V. W.; Gill, R. R.; Simone, C. B. 2nd; Zauderer, M.; Yorke, E. D.; Li, Z.; Peikert, T. D.; Voong, R.; more...
International Journal of Radiation Oncology, Biology, Physics (2021)

Fulltext@MSK | Save

A phase I trial of regional mesothelin-targeted CAR T-cell therapy in patients with malignant pleural disease, in combination with the anti-PD-1 agent pembrolizumab

Journal Article

Adusumilli, P. S.; Zauderer, M. G.; Rivière, I.; Solomon, S. B.; Rusch, V. W.; O'Cearbhaill, R. E.; Zhu, A.; Cheema, W.; Chintala, N. K.; Halton, E.; more...
Cancer Discovery (2021)

Fulltext@MSK | Save

The use of a next-generation sequencing-derived machine-learning risk-prediction model (OncoCast-MPM) for malignant pleural mesothelioma: A retrospective study

Journal Article

Zauderer, M. G.; Martin, A.; Egger, J.; Rizvi, H.; Offin, M.; Rimner, A.; Adusumilli, P. S.; Rusch, V. W.; Kris, M. G.; Sauter, J. L.; more...
The Lancet Digital Health (2021)

Fulltext@MSK | Save

Phase 1 cohort expansion study of LY3023414, a dual PI3K/mTOR inhibitor, in patients with advanced mesothelioma

Journal Article

Zauderer, M. G.; Alley, E. W.; Bendell, J.; Capelletto, E.; Bauer, T. M.; Callies, S.; Szpurka, A. M.; Kang, S.; Willard, M. D.; Wacheck, V.; more...
Investigational New Drugs (2021)

Fulltext@MSK | Save

Utility of dual YAP/TAZ-NF2 immunohistochemistry in the diagnosis of malignant pleural mesothelioma and in predicting NF2 mutations

Meeting Abstract

Li, Y.; Chen, Y. B.; Zauderer, M.; Chang, J.; Offin, M.; Ladanyi, M.; Rekhtman, N.; Travis, W.; Yang, S. R.; Adusumilli, P.; more...
Modern Pathology (2021)

Fulltext@MSK | Save

Interpretation of methylthioadenosine phosphorylase (MTAP) expression by immunohistochemistry in malignant pleural mesothelioma is improved with monoclonal antibody 1813 compared to monoclonal antibody EPR6893

Meeting Abstract

Febres-Aldana, C.; Jungbluth, A.; Adusumilli, P.; Buonocore, D.; Chang, J.; Frosina, D.; Geronimo, J.; Hernandez, E.; Offin, M.; Rekhtman, N.; more...
Modern Pathology (2021)

Fulltext@MSK | Save

Assessing morphologic features in malignant pleural mesothelioma in cytology specimens: Reliability, utility and implications

Meeting Abstract

Salama, A.; Baine, M.; Adusumilli, P.; Buonocore, D.; Offin, M.; Zauderer, M.; Rekhtman, N.; Travis, W.; Lin, O.; Sauter, J.
Modern Pathology (2021)

Fulltext@MSK | Save

Correlation of histologic features with gene alterations in malignant pleural mesothelioma

Meeting Abstract

Yang, S. R.; Hsu, M.; Tan, K. S.; Adusumilli, P.; Chang, J.; Offin, M.; Rekhtman, N.; Travis, W.; Zauderer, M.; Ladanyi, M.; more...
Modern Pathology (2021)

Fulltext@MSK | Save